04-March-2014
Cerilliant now offers certified Snap-N-Spike® solutions of the new synthetic analgesic emerging drug of abuse AH-7921 and its D3 internal standard.
|
AH-7921 HCl, 1.0 mg/mL (as
|
A-113
|
1.0 mg/mL (as free base) in Methanol
This certified
Snap-N-Spike® solution is suitable for use as starting material in calibrators
and controls for AH-7921 LC-MS or GC/MS methods in clinical toxicology, urine
drug testing, or forensic analysis applications. AH-7921 is an opioid designer drug with
80% the potency of morphine when administered orally. First discovered in 2013,
AH-7921 is an active ingredient of synthetic cannabis found in Japan.
|
|
|
|
AH-7921-D3 HCl, 100 ug/mL
|
A-114
|
100 µg/mL (as free base) in Methanol
This stable-labeled
internal standard is suitable for quantitation of AH-7921 levels in urine or blood
by LC-MS or GC/MS methods in clinical toxicology, urine drug testing, or
forensic analysis applications. AH-7921 is an opioid designer drug with 80%
the potency of morphine when administered orally. First discovered in 2013,
AH-7921 is an active ingredient of synthetic cannabis found in Japan.
|
|
|
Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.
|